Review article: The history of acute infectious diarrhoea management - From poorly focused empiricism to fluid therapy and modern pharmacotherapy

Alimentary Pharmacology and Therapeutics

Volumn 25, Issue 7, 2007, Pages 759-769

  McMahan, Z H ^b   DuPont, H L ^a,c,d,e  

^a MC 1 164 ^*  (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d ST LUKE S EPISCOPAL HOSPITAL   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETORPHAN; ACETYLSALICYLIC ACID; ATROPINE PLUS DIPHENOXYLATE; ATTAPULGITE; AZITHROMYCIN; BISMUTH SALICYLATE; CASTOR OIL; CIPROFLOXACIN; COTRIMOXAZOLE; CROFELEMER; DILOXANIDE FUROATE; ENEMA; ERYTHROMYCIN STEARATE; KAOLIN; KAOLIN PECTIN; LEVOFLOXACIN; LOPERAMIDE; MERCUROUS CHLORIDE; METRONIDAZOLE; NITAZOXANIDE; NORFLOXACIN; OPIATE; ORAL REHYDRATION SOLUTION; PAROMOMYCIN; PECTIN; RIFAXIMIN; SODIUM CHLORIDE; TINIDAZOLE; VANCOMYCIN; ZALDARIDE MALEATE;

ACUTE DIARRHEA; ANAMNESIS; ANTICHOLINERGIC SYNDROME; ARMY; BACTERIAL TRANSMISSION; BACTERIUM ISOLATION; CAMPYLOBACTER; CLOSTRIDIUM DIFFICILE; CRYPTOSPORIDIUM; CYCLOSPORA; DRUG MEGADOSE; DYSENTERY; ENTAMOEBA HISTOLYTICA; ENTEROAGGREGATIVE ESCHERICHIA COLI; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROTOXIGENIC ESCHERICHIA COLI; FEVER; FLUID INTAKE; FLUID THERAPY; FOOD INTAKE; FOOD PROCESSING; GIARDIA; HEMATOCHEZIA; HISTORY OF MEDICINE; HUMAN; INFANTILE GASTROENTERITIS; INFECTION RATE; INFECTIOUS DIARRHEA; INFORMATION RETRIEVAL; INTESTINE FLORA; ISOSPORA; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDLINE; NEUROTOXICITY; NORWALK GASTROENTERITIS VIRUS; ORAL REHYDRATION THERAPY; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; REVIEW; ROTAVIRUS; SALMONELLA ENTERICA; SEASONAL VARIATION; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; SHIGELLA; SHIGELLA DYSENTERIAE; SHIGELLOSIS; SINGLE DRUG DOSE; TOOTH ERUPTION; TRAVELLER DIARRHEA;

ANALGESICS, OPIOID; ANTI-INFECTIVE AGENTS; CATHARTICS; DIARRHEA; FEMALE; FLUID THERAPY; FORECASTING; GASTROINTESTINAL AGENTS; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MALE;

EID: 33947251895     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03261.x     Document Type: Review

References (107)

1. Davison W. A bacteriological and clinical consideration of bacillary dysentery in adults and children. Medicine 1922; 1: 389-510.
2. Dingle J, McCorkle L, Badger G, et al. A study of illness in a group of Cleveland families. XIII. Clinical description of acute non-bacterial gastroenteritis. Amer J Hyg 1956; 64: 368-75.
3. Zahorsky J. Hyperemesis hiemis or the winter vomiting disease. Arch Pediat 1929; 46: 391-5.
4. Cook GC. Influence of diarrhoeal disease on military and naval campaigns. J R Soc Med 2001; 94: 95-7.
5. Kramer B, Kanof A. Diarrhea in children: a historical review. J Pediatr 1960; 57: 769-83.
6. Brieger GH. Health and disease on the western frontier. A bicentennial appreciation. West J Med 1976; 125: 28-35.
7. Evelina Hospital for Sick Children. Treatment of diarrhea. Lancet 1870; 1: 118.
8. Bollet AJ. Scurvy and chronic diarrhea in Civil War troops: were they both nutritional deficiency syndromes? J Hist Med Allied Sci 1992; 47: 49-67.
9. Partridge E. A Dictionary of Slang and Unconventional English. New York: THB Macmillan Co, 1956.
10. Booker W. A study of some of the bacteria found in the faeces of infants affected with summer diarrhea. Trans Amer Ped Soc 1889; 1: 198.
11. Brosco JP. The early history of the infant mortality rate in America: "A reflection upon the past and a prohecy of the future". Pediatrics 1999; 103: 478-85.
12. Escherich T. Articles adding to the knowledge of intestinal bacteria, III. on the existence of vibrios in the intestines and feces of babies [in German]. Munch Med Wochenschr 1986; 33: 815-7.
13. Losch F. Massenhafte Entwickelung von Amoben im Dickdarm. Virchows Arch Pathol Anat 1875; 65: 196-211.
14. Shiga K. The trend of prevention, therapy and epidemilogy of dysentery since the discovery of its causative organism. N Engl J Med 1936; 215: 1205-11.
15. Simpson J. The treatment of diarrhea. New York Med J 1915; 102: 145-7.
16. Evans PR. A hundred years of children's hospitals: the centenary of the Evelina Hospital for Sick Children. Proc R Soc Med 1970; 63: 44-6.
17. Osler W. Principles and Practices of Medicine, 1st edn. Edinburgh and London: Young J, 1892.
18. Holt L. The antiseptic treatment of summer diarrhea. Boston Med Surg J 1887; 116: 190-2.
19. Passmore R. On putting two and two together: osmosis and cholera. Chron R Coll Physicians Edinb 1986; 16: 168-80.
20. Stevens W. Observations on the Treatment of Cholera: C. Groebe & Son, Copenhagen, 1833.
21. Billings J. Cholera Epidemic of 1873. Government Printing Office, Washington, DC; 1875.
22. Ruxin JN. Magic bullet: the history of oral rehydration therapy. Med Hist 1994; 38: 363-97.
23. Phillips R. Water and electrolyte losses in cholera. Fed Proc 1964; 23: 705-12.
24. Savarino SJ. A legacy in 20th-century medicine: Robert Allan Phillips and the taming of cholera. Clin Infect Dis 2002; 35: 713-20.
25. Riklis E, Haber B, Quastel JH. Absorption of mixtures of sugars by isolated surviving guinea pig intestine. Can J Biochem Physiol 1958; 36: 373-80.
26. Riklis E, Quastel JH. Effects of cations on sugar absorption by isolated surviving guinea pig intestine. Can J Biochem Physiol 1958; 36: 347-62.
27. Schultz SG, Zalusky R. Ion transport in isolated rabbit ileum. II. The interaction between active sodium and active sugar transport. J Gen Physiol 1964; 47: 1043-59.
28. Field M. Ion transport in rabbit ileal mucosa. II. Effects of cyclic 3′, 5′-AMP. Am J Physiol. 1971; 221: 992-7.
29. Field M, Fromm D, al-Awqati Q, WB 3rd Greenough. Effect of cholera enterotoxin on ion transport across isolated ileal mucosa. J Clin Invest 1972; 51: 796-804.
30. Field M, Graf Jr LH, Laird WJ, Smith PL. Heat-stable enterotoxin of Escherichia coli: in vitro effects on guanylate cyclase activity, cyclic GMP concentration, and ion transport in small intestine. Proc Natl Acad Sci USA 1978; 75: 2800-4.
31. Fordtran JS. Speculations on the pathogenesis of diarrhea. Fed Proc 1967; 26: 1405-14.
32. Hirschhorn N, Kinzie JL, Sachar DB, et al. Decrease in net stool output in cholera during intestinal perfusion with glucose-containing solutions. N Engl J Med 1968; 279: 176-81.
33. Kielmann AA, Mobarak AB, Hammamy MT, et al. Control of deaths from diarrheal disease in rural communities. I. Design of an intervention study and effects on child mortality. Trop Med Parasitol 1985; 36: 191-8.
34. Victora CG, Bryce J, Fontaine O, Monasch R. Reducing deaths from diarrhoea through oral rehydration therapy. Bull World Health Organ 2000; 78: 1246-55.
35. Hahn S, Kim S, Garner P. Reduced osmolarity oral rehydration solution for treating dehydration caused by acute diarrhoea in children. Cochrane Database Syst Rev 2002; (1): CD002847.
36. Santosham M, Fayad I, Abu Zikri M, et al. A double-blind clinical trial comparing World Health Organization oral rehydration solution with a reduced osmolarity solution containing equal amounts of sodium and glucose. J Pediatr 1996; 128: 45-51.
37. Lebenthal E, Khin Maung U, Rolston DD, et al. Thermophilic amylase-digested rice-electrolyte solution in the treatment of acute diarrhea in children. Pediatrics 1995; 95: 198-202.
38. Raghupathy P, Ramakrishna BS, Oommen SP, et al. Amylase-resistant starch as adjunct to oral rehydration therapy in children with diarrhea. J Pediatr Gastroenterol Nutr 2006; 42: 362-8.
39. Ramakrishna BS, Venkataraman S, Srinivasan P, Dash P, Young GP, Binder HJ. Amylase-resistant starch plus oral rehydration solution for cholera. N Engl J Med 2000; 342: 308-13.
40. Giblin J, Lischner M. The treatment of enteritis in infants and children with the raw apple diet. Arch Pediatr 1935; 52: 355-9.
41. Manville I, Bradway E, McMinis A. The use of apple powder in the treatment of diarrheal conditions and its rationale. Canad Med Assoc J 1937; 36: 252-7.
42. Sorrontino C. Therapeutic efficacy of cerain substances contained in apples in diarrhea in children. JAMA 1936; 107: 392.
43. Kutscher G. The role of pectin in diarrhea. N Carolina Med J 1940; 1: 107-8.
44. Werch S, Jung R, Plenk H, Day A, Ivy A. Pectin and galacturonic acid and the intestinal pathogens. Am J Dis Child 1942; 63: 839-46.
45. Portnoy BL, DuPont HL, Pruitt D, Abdo JA, Rodriguez JT. Antidiarrheal agents in the treatment of acute diarrhea in children. JAMA 1976; 236: 844-6.
46. Reves R, Bass P, DuPont HL, Sullivan P, Mendiola J. Failure to demonstrate effectiveness of an anticholinergic drug in the symptomatic treatment of acute travelers' diarrhea. J Clin Gastroenterol 1983; 5: 223-7.
47. Ahmad SR. Lomotil overdose. Pediatrics 1992; 89: 980-1.
48. Michael JB, Sztajnkrycer MD. Deadly pediatric poisons: nine common agents that kill at low doses. Emerg Med Clin North Am 2004; 22: 1019-50.
49. DuPont HL, Flores Sanchez J, Ericsson CD, et al.Comparative efficacy of loperamide hydrochloride and bismuth subsalicylate in the management of acute diarrhea. Am J Med 1990; 88(Suppl 6A): 15S-9S.
50. Johnson PC, Ericsson CD, DuPont HL, Morgan DR, Bitsura JA, Wood LV. Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers' diarrhea. JAMA 1986; 255: 757-60.
51. Schiller LR, Santa Ana CA, Morawski SG, Fordtran JS. Mechanism of the antidiarrheal effect of loperamide. Gastroenterology 1984; 86: 1475-80.
52. Palmer KR, Corbett CL, Holdsworth CD. Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea. Gastroenterology 1980; 79: 1272-5.
53. DuPont HL, Sullivan P, Pickering LK, Haynes G, Ackerman PB. Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican university. Gastroenterology 1977; 73: 715-8.
54. Powell DW, Tapper EJ, Morris SM. Aspirin-stimulated intestinal electrolyte transport in rabbit ileum in vitro. Gastroenterology 1979; 76: 1429-37.
55. Burke V, Gracey M, Suharyono , Sunoto . Reduction by aspirin of intestinal fluid-loss in acute childhood gastroenteritis. Lancet 1980; 1: 1329-30.
56. Zhang W, Mannan I, Schulz S, et al. Interruption of transmembrane signaling as a novel antisecretory strategy to treat enterotoxigenic diarrhea. FASEB J 1999; 13: 913-22.
57. Thiagarajah JR, Broadbent T, Hsieh E, Verkman AS. Prevention of toxin-induced intestinal ion and fluid secretion by a small-molecule CFTR inhibitor. Gastroenterology 2004; 126: 511-9.
58. Fischer H, Machen TE, Widdicombe JH, et al. A novel extract SB-300 from the stem bark latex of Croton lechleri inhibits CFTR-mediated chloride secretion in human colonic epithelial cells. J Ethnopharmacol 2004; 3: 351-7.
59. Matheson AJ, Noble S. Racecadotril. Drugs. 2000;59: 829-35; discussion 836-7.
60. DuPont HL, Ericsson CD, Mathewson JJ, Marani S, Knellwolf-Cousin AL, Martinez-Sandoval FG. Zaldaride maleate, an intestinal calmodulin inhibitor, in the therapy of travelers' diarrhea. Gastroenterology 1993; 104: 709-15.
61. DuPont HL, Formal SB, Hornick RB, et al. Pathogenesis of Escherichia coli diarrhea. N Engl J Med 1971; 285: 1-9.
62. Gorbach SL, Banwell JG, Chatterjee BD, Jacobs B, Sack RB. Acute undifferentiated human diarrhea in the tropics. I. Alterations in intestinal micrflora. J Clin Invest 1971; 50: 881-9.
63. Butzler JP, Dekeyser P, Detrain M, Dehaen F. Related vibrio in stools. J Pediatr. 1973; 82: 493-5.
64. Bishop RF, Davidson GP, Holmes IH, Ruck BJ. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet 1973; 2: 1281-3.
65. Dolin R, Blacklow NR, DuPont H, et al. Biological properties of Norwalk agent of acute infectious nonbacterial gastroenteritis. Proc Soc Exp Biol Med 1972; 140: 578-83.
66. Frenzen PD. Mortality due to gastroenteritis of unknown etiology in the United States. J Infect Dis 2003; 187: 441-52.
67. Kilgore PE, Holman RC, Clarke MJ, Glass RI. Trends of diarrheal disease-associated mortality in US children, 1968 through 1991. JAMA 1995; 274: 1143-8.
68. Caeiro JP, DuPont HL, Albrecht H, Ericsson CD. Oral rehydration therapy plus loperamide versus loperamide alone in the treatment of traveler's diarrhea. Clin Infect Dis 1999; 28: 1286-9.
69. Sale E. Posture as an important adjunct in the treatment of diarrhea and dysentery. Amer J Med Sci 1871; 62: 573-4.
70. Selander P. Carrot soup in the treatment of infantile diarrhea. J Pediatr 1950; 36: 742-5.
71. Smith A, Fischer C. The use of carob flour in the treatment of diarrhea in infants and children. J Pediatr 1949; 35: 422-6.
72. DuPont HL. Bismuth subsalicylate in the treatment and prevention of diarrheal disease. Drug Intell Clin Pharm 1987; 21: 687-93.
73. DiCesare D, DuPont HL, Mathewson JJ, et al. A double blind, randomized, placebo-controlled study of SP-303 (Provir) in the symptomatic treatment of acute diarrhea among travelers to Jamaica and Mexico. Am J Gastroenterol 2002; 97: 2585-8.
74. Okhuysen PC, DuPont HL, Ericsson CD, et al. Zaldaride maleate (a new calmodulin antagonist) versus loperamide in the treatment of traveler's diarrhea: randomized, placebo-controlled trial. Clin Infect Dis 1995; 21: 341-4.
75. Siberschmidt G, Schick, MT, et al. Treatment of travellers' diarrhoea: zaldaride compared with loperamide and placebo. European Journal of Gastroenterol Hep 1995; 7: 871-5.
76. Bassily S, Hyams KC, el-Masry NA, et al. Short-course norfloxacin and trimethoprim-sulfamethoxazole treatment of shigellosis and salmonellosis in Egypt. Am J Trop Med Hyg 1994; 51: 219-23.
77. Bennish ML, Salam MA, Haider R, Barza M. Therapy for shigellosis. II. Randomized, double-blind comparison of ciprofloxacin and ampicillin. J Infect Dis 1990; 162: 711-6.
78. Bennish ML, Salam MA, Khan WA, Khan AM. Treatment of shigellosis: III. Comparison of one- or two-dose ciprofloxacin with standard 5-day therapy. A randomized, blinded trial. Ann Intern Med 1992; 117: 727-34.
79. Bhattacharya SK, Bhattacharya MK, Dutta P, et al. Randomized clinical trial of norfloxacin for shigellosis. Am J Trop Med Hyg 1991; 45: 683-7.
80. Khan WA, Seas C, Dhar U, Salam MA, Bennish ML. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial. Ann Intern Med 1997; 126: 697-703.
81. Biedenbach DJ, Toleman M, Walsh TR, Jones RN. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Diagn Microbiol Infect Dis 2006; 54: 13-21.
82. Devasia RA, Varma JK, Whichard J, et al. Antimicrobial use and outcomes in patients with multidrug-resistant and pansusceptible Salmonella Newport infections, 2002-2003. Microb Drug Resist 2005; 11: 371-7.
83. Ruiz M, Rodriguez JC, Escribano I, Royo G. Available options in the management of non-typhi Salmonella. Expert Opin Pharmacother 2004; 5: 1737-43.
84. Soe GB, Overturf GD. Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, ceftriaxone, cefoperazone, and other newer cephalosporins. Rev Infect Dis 1987; 9: 719-36.
85. Adachi JA, Ericsson CD, Jiang ZD, et al. Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. Clin Infect Dis 2003; 37: 1165-71.
86. DuPont HL, Jiang ZD, Ericsson CD, et al. Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis 2001; 33: 1807-15.
87. Ericsson CD, DuPont HL, Mathewson JJ. Optimal dosing of ofloxacin with loperamide in the treatment of non-dysenteric travelers' diarrhea. J Travel Med 2001; 8: 207-9.
88. Salam I, Katelaris P, Leigh-Smith S, Farthing MJ. Randomised trial of single-dose ciprofloxacin for travellers' diarrhoea. Lancet 1994; 344: 1537-9.
89. Mandal BK, Ellis ME, Dunbar EM, Whale K. Double-blind placebo-controlled trial of erythromycin in the treatment of clinical Campylobacter infection. J Antimicrob Chemother 1984; 13: 619-23.
90. Salazar-Lindo E, Sack RB, Chea-Woo E, et al. Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children. J Pediatr 1986; 109: 355-60.
91. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolyticuremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 2000; 342: 1930-6.
92. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 1997; 92: 739-50.
93. Olson MM, Shanholtzer CJ, Lee Jr JT, Gerding DN. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol. 1994; 15: 371-81.
94. Levi GC, de Avila CA, Amato Neto V. Efficacy of various drugs for treatment of giardiasis. A comparative study. Am J Trop Med Hyg 1977; 26: 564-5.
95. Masry NA, Farid Z, Miner WF. Treatment of giardiasis with tinidazole. Am J Trop Med Hyg 1978; 27: 201-2.
96. Speelman P. Single-dose tinidazole for the treatment of giardiasis. Antimicrob Agents Chemother 1985; 27: 227-9.
97. Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis 2001; 184: 103-6.
98. Rossignol JF, Kabil SM, el-Gohary Y, Younis AM. Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species. Clin Gastroenterol Hepatol 2006; 4: 320-4.
99. Pape JW, Verdier RI, Johnson Jr WD. Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome. N Engl J Med 1989; 320: 1044-7.
100. DeHovitz JA, Pape JW, Boncy M, Johnson WD Jr. Clinical manifestations and therapy of Isospora belli infection in patients with the acquired immunodeficiency syndrome. N Engl J Med 1986; 315: 87-90.
101. Pape JW, Verdier RI, Boncy M, Boncy J, Johnson WD, Jr. Cyclospora infection in adults infected with HIV. Clinical manifestations, treatment, and prophylaxis. Ann Intern Med 1994; 121: 654-7.
102. Blessmann J, Binh HD, Hung DM, Tannich E, Burchard G. Treatment of amoebic liver abscess with metronidazole alone or in combination with ultrasound-guided needle aspiration: a comparative, prospective and randomized study. Trop Med Int Health. 2003; 8: 1030-4.
103. McAuley JB, Herwaldt BL, Stokes SL, et al. Diloxanide furoate for treating asymptomatic Entamoeba histolytica cyst passers: 14 years' experience in the United States. Clin Infect Dis. 1992; 15: 464-8.
104. McAuley JB, Juranek DD. Paromomycin in the treatment of mild-to-moderate intestinal amebiasis. Clin Infect Dis 1992; 15: 551-2.
105. McAuley JB, Juranek DD. Luminal agents in the treatment of amebiasis. Clin Infect Dis 1992; 14: 1161-2.
106. Simjee AE, Gathiram V, Jackson TF, Khan BF. A comparative trial of metronidazole v. tinidazole in the treatment of amoebic liver abscess. S Afr Med J 1985; 68: 923-4.
107. DuPont HL. Azithromycin for the self-treatment of traveler's diarrhea. Clin Infect Dis. 2007; 44: 347-9.